Sign in
4

Changes in Ownership

TScan Therapeutics, Inc. Filed Acc 0000899243-21-049764

Chief Executive Officer acquired 48,670 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
SOUTHWELL DAVID P Chief Executive Officer 2021-12-23 Option exercise +48,670 $1.97 $95,880 146,569 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
SOUTHWELL DAVID P Chief Executive Officer 2021-12-23 Option exercise · Stock Option (Right to Buy) −48,670 21,161 D: show line 2 in the form
Loading xslF345X03/doc4.xml…